| WMS 2010 Young Investigator Prizes - Kumamoto | ||||||||
| Presentation | Author | Title | ||||||
| Lea Rose Prize on SMA: | ||||||||
| O.18 | Martine Barkats | Intravenous injection of SMN1-expressing self-complementary AAV9 rescues severe type 1 SMA mice | ||||||
| President's Prize: Young Myologist of the Year | ||||||||
| O.11 | Satomi Mitsuhashi | A novel congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis | ||||||
| President's Prize: First Time Presenter | ||||||||
| O.1 | Takako Moriguchi | Novel O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding: implications for congenital muscular dystrophy | ||||||
| Elsevier Prizes (4) | ||||||||
| O.9 | Veronique Bolduc | Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies | ||||||
| O.3 | Perrine Castets | Satellite cell loss is the pathomechanism leading to muscle atrophy in selenoprotein N deficiency | ||||||
| O.7 | May Malicdan | Novel approach to sialic acid therapy in DMRV/hIBM mouse model | ||||||
| P1.45 | Karim Hnia | The phosphoinositide phosphatase myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in muscle | ||||||
| Subscription Prize | ||||||||
| Presentation | Author | Title | ||||||
| 1 | O.4 | Anne Bertrand | Mouse model of LMNA-congenital muscular dystrophy shows severe skeletal and cardiac muscle maturation defects associated with major metabolic defects leading to early death | |||||
| 2 | O.8 | Tomoharu Tokutomi | Treatment of hyposialylation in mouse model of DMRV/hIBM with novel synthetic sugar compounds | |||||
| 3 | O.17 | Nicolas Wein | Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping | |||||
| 4 | P1.02 | Alasdair Wood | Abnormal angiogenesis in zebrafish models for FKRP and fukutin deficiency | |||||
| 5 | P1.03 | Motoi Kanagawa | Disruption of dystroglycan-pikachurin interaction underlies the molecular pathogenesis of eye abnormalities in dystroglycanopathy | |||||
| 6 | P1.18 | Verena Schoewel | Dysferlin peptides elicit functional recovery in dysferlin deficient muscular dystrophy | |||||
| 7 | P1.39 | Saba Abdul-Hussein | Transfection of cultured myoblast with mutant alpha-tropomyosin (TPM2EGFP) | |||||
| 8 | P1.47 | Monica Mezmezian | Retrospective analysis of 309 muscle biopsies performed exclusively during the neonatal period | |||||
| 9 | P1.49 | Manoj Menezes | The importance and challenge of diagnosing myopathies due to LMNA | |||||
| 10 | P2.22 | Shinya Honda | Lamp-1 overexpression rescues cardiomyopathy in Lamp-2 deficient cells by correcting cellular lysosomal function | |||||
| 11 | P3.17 | Etienne Mouisel | Lack of myostatin impairs oxidative metabolism and exercise performance | |||||
| 12 | P3.19 | Jessica Simmers | Decrease of sarcolemmal nNOS as a molecular marker of muscle atrophy in inherited and acquired forms of myopathy | |||||
| 13 | P3.47 | Tyesha Burks | Administration of Losartan improves skeletal muscle repair in mice with carcopenia | |||||
| 14 | P4.45 | Sayuri Sukigara | Muscle glycogen storage disease type 0b presenting recurrent post-exercise loss of consciousness with weakness and myalgia | |||||
| 15 | P4.46 | Johanna Nilsson | Molecular pathogenesis of a new glycogenosis caused by a mutation in glycogenin-1 | |||||
Published on 31 October 2010.
05 Nov 2025 WMS 2025 prizewinners
02 Dec 2024 Prize Winners - WMS Congress 2024
29 Nov 2023 Prize Winners - WMS Congress 2023
